Just-in-time cell supply for cell-based high-throughput screening (HTS) is frequently problematic. In addition to scheduling and logistical issues, quality issues and variability due to passage effect, cell cycle, or confluency contribute to day-to-day signal variability in the course of cell-based HTS campaigns. Cell division-arrest and cryopreservation technologies permit the use of cells as assay-ready reagents for HTS and other cell-based profiling and structure-activity studies. In this report, the authors compare division-arrested and dividing cells in 2 assay types that are dependent on movement of proteins within or through cell membranes: a receptor tyrosine kinase assay involving A431 cells responsive to epidermal growth factor, and a secretion reporter assay, which measures secretion of a reporter gene, secreted alkaline phosphatase. In both assays, dividing and division-arrested cells yielded similar basal and maximal signals at a given cell density. Similar IC 50 s were obtained for reference inhibitors in each assay, type in both dividing and division-arrested cells. In addition, for the secretion reporter assay, when comparing IC 50 s obtained from 44 compounds randomly chosen from a primary screening hit list, the rank order of potency obtained from dividing cells and division-arrested cells was essentially identical. Furthermore, the results show that, under certain assay conditions, data generated using division-arrested cells are less variable than those generated using dividing cells. In summary, the results suggest that, in many cases, division-arrested cells can substitute for dividing cells and offer certain advantages for cell-based assays. (Journal of Biomolecular Screening 2005:615-623) 
INTRODUCTION
T HE USE OF CELL-BASED ASSAYS in drug discovery and in highthroughput screening (HTS) and compound profiling has increased steadily in the past several years. Cell-based screening, in which the target activity is directly assessed in its cellular environment, can improve the quality and biological relevance of active compounds in comparison to isolated biochemical target-based screening. Various cell-based assays such as reporter gene assays, secondary messenger assays, cell-based enzyme-linked immunosorbent assay (ELISA), cell-based proximity assays, and pathway screening are used extensively in current HTS. Despite the widespread use of these assays in drug discovery, the on-time provision of cells for cell-based HTS campaigns is frequently problematic. In addition to the logistical issues involving coordination of cell supply with assay timelines, quality issues such as timedependent loss or fluctuation of protein expression level, as well as cell cycle, passage, or confluency effects, contribute to variability in cell-based HTS processes. As a result, cell-based screens often yield data with higher variability than do biochemical screens. Variability and inconsistency in cell quality can result in lowquality assays and low-quality screening data. One way to alleviate cell supply inconsistency and scheduling problems is by using automated cell culturing systems in alignment with automated HTS systems. However, automated cell culturing systems are not only formidably expensive for many HTS laboratories, but their use does not address issues of variability inherent in the use of dividing cells.
An alternative strategy to the use of dividing cells for cell-based assays involves the use of cryopreserved, division-arrested cells. One such cell treatment method has been described and made commercially available recently. [1] [2] [3] 9 The division-arrest technology uses a pulse treatment with low doses of mitomycin C to prevent cell division. Cells are cryopreserved and alive after thawing but only minimally divide. This cell treatment allows for frozen, assay-ready cells for use in HTS, compound profiling, and structure-activity studies. The advantages of division-arrested cells in-clude convenience of use and consistency of assay signal output. Division-arrested cells have been shown to respond to stimuli in reporter gene assays using the intracellular reporters, luciferase and beta-lactamase, and in G-protein-coupled receptor (GPCR) assays measuring intracellular Ca ++ and cAMP concentrations. [1] [2] [3] 9 In this report, we explore the use of 2 division-arrested cell lines in 2 cell-based assays whose readout depends on the movement of proteins within or between biological membranes: a receptor tyrosine kinase (RTK) assay involving A431 cells responsive to epidermal growth factor (EGF) and a protein secretion assay, using the secreted reporter gene, secreted alkaline phosphatase (SEAP). Our results indicate that these cell-based assays can be conducted using division-arrested cells, and that, despite their minimal proliferative capacity, division-arrested cells retain many normal metabolic functions.
MATERIALS AND METHODS
Cell culture and division-arrest. The A431 human epidermoid carcinoma cell line was obtained from ATCC (CRL1555) and cultivated in Dulbecco's modified Eagle's medium (DMEM) with 4 g/L glucose, 4 mM L-glutamine, and 1.5 g/L sodium bicarbonate supplemented with 10% heat-inactivated fetal bovine serum. Genetically engineered HEK293/SEAP cells (kindly provided by Ivan Lindley's laboratory, Novartis, Vienna, Austria) were propagated in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 100 U/mL penicillin, 100 µg/mL streptomycin, 1% Glutamax ™ , and 0.5 µg/mL puromycin. All cell culture reagents were purchased from Invitrogen (Carlsbad, CA), with the exception of puromycin, which was purchased from Sigma-Aldrich (St. Louis, MO).
For division-arrest, cells were treated by Cell and Molecular Technologies (North Wales, PA), using their proprietary procedures. The treated cells were stored until use in aliquots of 2 × 10e6 cells/vial for A431 or 10e7 cells/vial for HEK293/SEAP cells in a liquid nitrogen freezer. For use, division-arrested cells were quickly thawed at 37°C, washed once and resuspended in fresh media, and counted and diluted to the desired concentration in complete media. For the receptor tyrosine kinase assay, divisionarrested cells were incubated for approximately 6 h prior to the serum starvation treatment. The division-arrested HEK293/SEAP cells were left overnight prior to tumor necrosis factor-alpha (TNF-α) stimulation (Pepro Tech, Rocky Hill, NJ).
RTK capture ELISA assay in A431 cells
Sample preparation. Normally cultured dividing cells or division-arrested A431 cells were seeded in 96-well tissue culture plates at the desired cell density and cultured in complete medium for 6 h. Medium was changed to serum-free medium, and cells were serum starved overnight. Cells in control wells were either untreated or treated by the addition of human epidermal growth factor (EGF; Sigma E-9644) in serum-free medium. Cells receiv-ing test compounds were left in serum-starving medium. Appropriate dilutions of each compound were added to triplicate wells for 90 min at 37°C prior to the addition of the indicated concentration of EGF. EGF stimulation was for 15 min at 37°C. After stimulation, cells were washed twice with ice-cold phosphate-buffered saline (PBS), lysed for 15 min on ice with 150 µL/well freshly prepared lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM sodium chloride, 5 mM EDTA, 1 mM EGTA, 1% NP-40, 2 mM sodium ortho-vanadate, 1 mM PMSF, 50 µg/mL aprotinin, and 80 µg/mL leupeptin), and shaken for 10 min on a 96-well plate shaker at room temperature. The lysates were either used immediately or stored for later use at -20°C in the 96-well plates sealed with plate sealers.
Compound handling. Test compounds (10 mM in 100% DMSO stock solution) were diluted manually in serum-free medium immediately prior to cell addition. Compounds were serially diluted in 11 points from 10 µM to 0.06 nM. DMSO showed no interference in the assay, even at the highest compound concentration used (0.1% DMSO).
Capture ELISA assay for EGF-R phosphorylation. A capture ELISA assay 4 was used to measure phosphorylation of the EGFreceptor (EGF-R) in response to EGF. Microplates (Packard HTRF-96 black) were coated with 40 ng/well affinity-purified goat anti-EGF-R extracellular domain antibody (cat. no. AF231 R & D Systems, Minneapolis, MN) in 100 µL PBS overnight at 4°C
. After washing with PBST (20 mM Tris-HCl, 0.13 M sodium chloride, 0.05% Tween-20, pH 7.6), residual protein binding sites were blocked with blocking buffer (PBST plus 2% bovine serum albumin [BSA]) for 2 h at room temperature. The plates were then washed 3 times with PBST and once with high-performance liquid chromatography (HPLC)-grade water. For sample addition, 100 µL/well of the total 150-µL prepared cell lysate was transferred to the ELISA plate and incubated for 2 to 4 h at room temperature. The plates were washed 3 times with PBST and once with HPLCgrade water and incubated overnight at 4°C with 100 µL/well of alkaline phosphatase-conjugated antiphosphotyrosine monoclonal antibody (PY20-AP; cat. no. 03-7722, prediluted 1:2000 in lysis buffer ZYMED, South San Francisco, CA). The plates were washed again 3 times with PBST and once with HPLC-grade water. For detection, 120 µL/well chemiluminescent substrate (CDP-Star RTU with Emerald II, Applied Biosystems, Bedford, MA) was added and incubated for 45 min at room temperature in the dark. Luminescence was measured as counts per second (cps) with an Envision 2100 ™ plate reader using an appropriate emission filter and mirror settings for luminescence at 700 nm.
TNF--induced secretion assay
Compound handling. Test compounds were provided in 384well polypropylene plates containing 44 compounds/plate, with each compound serially diluted (1:3.16 dilution) in 100% DMSO to produce an 8-point dilution series. The most concentrated solu-tion was 2-mM compound. Due to DMSO sensitivity of the HEK293/SEAP cells, compounds required dilution to a tolerable DMSO concentration (i.e., 0.2% DMSO) prior to use. To accomplish this, compounds in DMSO were first diluted by a factor of 1:50 with HPLC-grade water, and 4 µL/well was transferred to dry NUNC 384-well, tissue culture-treated black plates (NUNC cat. no. 164564) using the PlateMate Plus ™ liquid handler.
SEAP secretion assay. Normally cultured, dividing HEK293/ SEAP cells were dissociated from the tissue culture flasks using trypsin-EDTA (Invitrogen, cat. no. 25200-056) and counted. Division-arrested cells were quickly thawed at 37°C, washed once in fresh media, resuspended, and counted. Both cell types were diluted to 1.5 × 10 6 cells/mL, that is, 3000 cells/20 µL in media containing 10% fetal bovine serum (FBS). A portion of cells was set aside for nonstimulated controls. To the rest of the cells, TNF-α was added at 150 ng/mL (3× the final concentration, prepared in buffer containing 1× Hank's balanced salt solution, 20 mM HEPES [pH 7.4], and 0.1% BSA). Cells were dispensed at 30 µL/ well into appropriate wells of the NUNC plates containing test compounds diluted as described above, using the Multidrop ™ multiwell liquid dispenser. Plates were briefly centrifuged and then placed in the incubator, at 37°C, 5% CO 2 , for 23 h. For assaying SEAP activity, 30 µL/well of a 0.4-mM 4-methylumbelliferyl phosphate solution (4-MUP; Sigma-Aldrich) was added using the Multidrop ™ liquid dispenser, giving a final concentration of 0.2 mM 4-MUP and a total assay volume of 64 µL/well. 4-MUP was prepared in buffer containing 2M glycine, 5.7 mM MgCl 2 , and 0.005% sodium azide and adjusted to pH 10. 4-MUP is a fluorogenic substrate for alkaline phosphatase, which gives a soluble fluorescent product, methylumbelliferone, whose fluorescence can be read at 440 nm. 5 After addition of the substrate, assay plates were centrifuged briefly and incubated at room temperature for 1 h before being read on the Envision ™ plate reader (PerkinElmer, Boston, MA) using reading conditions optimized for this assay. Control wells contained either unstimulated cells or stimulated cells with the same amount of DMSO without any compound.
Data analysis and curve fitting using GraphPad Prism ™

Dose-response curves in Figures 2 and 4 were generated with
GraphPad Prism ™ version 4.00 (GraphPad Software, San Diego, CA) using a nonlinear regression fitting following a classic 4parameter logistic equation. For the RTK data plotted in Figure 2 , we used data from "no EGF" stimulation for the 10 -4 M compound point and data from "no compound" for the 10 -12 M compound point. In Figure 4 , curve fitting was done on normalized data. Curves in Figure 5 and IC 50 reported in Table 1 were generated using a nonlinear regression fitting following a 3-parameter logistic equation derived from the classic 4-parameter logistic equation where the bottom variable was fixed to -100. For Figure 6 , a linear regression was generated using the same software.
RESULTS
Receptor tyrosine kinase assay: dose response to EGF in division-arrested and dividing A431 cells
In the RTK assay, the phosphorylation of EGF-R in response to EGF treatment was measured. This assay uses the well-known A431 human epidermal carcinoma cells, which have been used extensively for cell-based assays of EGF/EGF-R interaction. 6 Brief treatment with EGF induces dimerization of the EGF-R and activation of the protein tyrosine kinase. This activation results in autophosphorylation of the receptor, 6 which is measured using a capture ELISA assay. 4 The results of capture ELISA experiments designed to evaluate EGF response in both dividing and divisionarrested A431 cells are shown in Figure 1 .
In Figure 1A , phosphorylation of the EGF-R in dividing and division-arrested A431 cells is plotted as a function of cell number. Basal levels of phosphorylation seen at 40,000 cells/well of unstimulated cells were also plotted for comparison. In this assay, 50 ng/mL of EGF was used. The signal increases with cell number for both cell types, approaching a plateau at about 40,000 cells/well. At 40,000 cells/well, the signal-to-background (S/B) ratio of 24 was seen for dividing cells versus a S/B ratio of 25 for divisionarrested cells. It should be noted that the assay protocol uses an overnight serum starvation, and therefore, it is expected that even the dividing cells are only minimally dividing. This result can be contrasted with the results shown for the SEAP secretion assay ( Fig. 3) , in which cells are maintained in complete media for the entire, approximately 24-h time course of the assay.
In Figure 1B , phosphorylation of the EGF-R is plotted as a function of EGF treatment. Dividing and division-arrested A431 cells plated at 40,000 cells/well were treated with various concentrations of EGF, and the phosphorylation status of the EGF-R was evaluated by capture ELISA. It can be seen from Figure 1A that both dividing and division-arrested A431 cells respond to EGF stimulation in a dose-dependent fashion by phosphorylating the EGF-R. Both the basal and maximal phosphorylation levels achieved appear similar comparing division-arrested cells to dividing cells, with maximal signal reached between 50 and 100 ng/ml EGF in both cell types. Maximal S/B ratios ranged from 23 to 27 using 50 ng/mL or 100 ng/mL EGF in both cell types. In subsequent experiments, 50 ng/mL EGF was chosen for EGF-R phosphorylation. At this EGF concentration, a S/B of 24 and a Z′ factor 7 of 0.8 were seen in the dividing A431 cells. These values were very close to those from division-arrested A431 cells (S/B = 25 and Z′ factor = 0.8).
shown in Figure 2 . The inhibitors, termed compounds 1 and 2 in Figure 2 , were tested in 11-fold serial dilution experiments spanning a 6-log dilution range. The IC 50 s seen with both compounds were quite similar in the dividing and the division-arrested cells. The IC 50 s obtained using dividing cells were 9 nM for compound 1 and 4 nM for compound 2. The IC 50 values for division-arrested cells were 14 nM for compound 1 and 17 nM for compound 2. The dose-response curves generated from the division-arrested cells were slightly shifted rightward, indicating that the division-arrested cells were less sensitive to both compounds relative to the dividing A431 cells. Nevertheless, the overall shape of the inhibition dose-response curves was quite similar to each other in the 2 cell types. Thus, it appears that the EGF-R tyrosine kinase in the division-arrested cells functions similarly to that in the dividing A431 cells. Despite the cell division-arrest treatment, the EGF-R is apparently able to dimerize and autophosphorylate similarly to nontreated A431 cells. In all points, 40,000 cells/well and 50 ng/mL epidermal growth factor (EGF) were used. Compounds were preincubated with cells for 90 min prior to stimulation of cells with EGF for 15 min at 37°C. Each point represents the mean ± standard deviation of triplicate measurements. 
Protein secretion assay: signal window, cell number response, DMSO sensitivity, and control compound response
The second assay type used a HEK293-derived recombinant cell line in which activity of the macrophage inflammatory protein-3α (MIP-3α) promoter 8 is measured via activity of SEAP in the cell supernatant. Transcription from this promoter is stimulated by TNF-α. The assay is dependent on correct transcription, translation, and movement of SEAP through the endoplasmic reticulum/Golgi secretion pathway. Presence of SEAP in the cell supernatant is measured using fluorescence-based detection of alkaline phosphatase activity.
In Figure 3 , SEAP activity in response to TNF-α stimulation in both dividing and division-arrested HEK293/SEAP cells is shown. The results of experiments using 3000 cells/well, either uninduced or induced with 50 ng/mL TNF-α overnight, are shown in Figure  3A . SEAP activity is inducible by the addition of TNF-α in both dividing cells and division-arrested cells. However, the maximal activity levels attained with the 2 cell types differ substantially, with the dividing cells giving a higher SEAP activity than the divisionarrested cells. Because SEAP activity was measured~24 h after induction, dividing cells are expected to have significantly outnumbered the division-arrested cells when the measurement was conducted. The results shown in Figure 3B indicate that from 3000 to 12,000 cells/well, the signals generated were proportional to the cell number used in the division-arrested cells. Therefore, the difference in maximal response at 3000 cells/well seen in Figure 3A between dividing and division-arrested cells is almost certainly due to continuing cell proliferation in the dividing cells during thẽ 24-h incubation step in this assay. In the division-arrested cells, little obvious cell growth was observed during the same incubation period (data not shown), which is consistent with the observation for other division-arrest-treated cell lines. 2, 3, 9 The DMSO tolerance and response to the control inhibitor were tested, comparing dividing HEK293/SEAP cells to divisionarrested HEK293/SEAP cells. Using 3000 cells/well for each cell type, it can be seen that responses to DMSO are nearly identical in the 2 cell types (Fig. 4A) ; both can tolerate up to 0.25% DMSO. In addition, both cell types showed similar inhibition dose-response curves for an internal control compound (Fig. 4B) . The IC 50 measured was 67 nM for the division-arrested cells versus 85 nM for the dividing cells.
Secretion assay: dose-response comparison for 44 compounds
The IC 50 was determined for 44 compounds derived from a primary hit list in an effort to make a more comprehensive comparison of division-arrested and dividing HEK293/SEAP cells. Among the 44 compounds tested, 37 compounds were shown to be active, and 7 compounds were inactive in both cell types. Doseresponse curves for 22 of the 44 compounds are shown in Figure 5 . Analyses of these 44 compounds in the 2 cell types are summarized in Table 1 . From the titration curves and analyses, 3 points are apparent: 1) The overall shapes of the dose-response curves are similar for the dividing and the division-arrested cells for each of the tested compounds, 2) active and inactive compounds are measured identically in the 2 cell types, and 3) the division-arrested cells appear slightly more sensitive to compound inhibition than the dividing cells. However, the relative rank order of the compound inhibitory potency is nearly identical from these 2 cell types. In addition, the data variability seen using the divisionarrested cells is less than that with the dividing cells. The overall standard deviation for all the measured data points for the 22 compounds shown in Figure 5 was 9% ± 6% for the dividing cells, whereas the overall standard deviation for division-arrested cells was 5% ± 3%. Figure 6 shows a comparison of the IC 50 curves in the 2 cell types for all 37 active compounds. Although not identical, the compound activities correlate well in the 2 cell types, with a correlation coefficient of 0.92 (Fig. 6 ).
DISCUSSION
Division-arrest technology has been described recently as an alternative to on-time cell supply for HTS and other cell-based assays. [1] [2] [3] 9 The examples provided in those reports include Ca ++ transport in antagonist assays, intracellular luciferase production in a reporter gene assay, and high-content reporter assays for transcription factor activation. In this report, we add 2 assays to the list of assay types in which the use of division-arrested cells is ex-pected to be successful: an RTK phosphorylation assay and a secretion reporter gene assay using the secreted reporter, SEAP. Both of the assays involve transport of proteins either within or through biological membranes, but the response time needed for the 2 as- says is quite different: 15 min for the RTK assay and > 24 h for the secretion assay. The side-by-side comparison of dividing and division-arrested cells looks most similar in the RTK assay. However, we believe that the benefit of using division-arrested cells may be maximized in assay types with long readout times due to the lack of error amplification caused by cell proliferation; the secretion reporter assay is an example of such an assay. For the RTK assay, very similar results were obtained comparing dividing and division-arrested cells. Comparisons performed included EGF response at a given cell number, response to varying EGF concentrations, and inhibition by control compounds. The results clearly indicate that the division-arrested A431 cells retain similar ligand-stimulated phosphorylation function relative to dividing cells, i.e., the EGF-R in the division-arrested cells is apparently able to dimerize and autophosphorylate similarly to dividing A431 cells.
Division-Arrested Cell Evaluation
In the secretion reporter assay, the results of direct comparison of division-arrested versus dividing cells were less compellingly similar due to the difference in absolute cell number at the end of the assay. However, TNF-α-induced response, DMSO response, and dose-response curves from treatment with known inhibitors were similar after data normalization in both dividing and divisionarrested HEK293/SEAP cells. Thus, division-arrested HEK293/ SEAP cells are capable of transcription, translation, and posttranslational translocation in this secretion reporter assay. Most importantly, using the secretion reporter assay, active and inactive compounds were identified correctly, and a nearly identical rank order of potency was obtained using dividing cells and division-arrested cells for 44 compounds (Table 1 and Fig. 5 ), indicating that the division-arrested cells can be substituted for dividing cells in HTS for this assay type.
The use of division-arrested cells has some advantages as well as shortcomings. Advantages include the following: 1. Consistency: Cells can be grown in a large, single batch for division-arrest treatment, minimizing passage effects and day-to-day cell variability. 2. Convenience: Cryopreservation uncouples cell growth from assay timelines. In addition to HTS, other fields expected to benefit from this uncoupling include cell-based compound profiling, in which multiple cell lines may be needed in one study, and structure-activity studies, in which a single cell-based assay may be used over months-years to characterize compounds. 3. Data quality: The use of division-arrested cells can enhance data quality by reducing cell growth-associated variability. This variability will be most apparent after a relatively long incubation period, which is necessary for many types of cell-based assays. The enhanced data quality seen from the use of division-arrested cells has been noted by others. 1, 2, 9 The lack of mechanistic information on how mitomycin C acts to affect division-arrest generates considerable concern and, to some extent, limits the utility of division-arrested cells. The division-arrest treatment, although yielding strikingly similar results in our tests, needs more characterization using other cell-based assay systems to capture a better picture of its effects. High doses and/or prolonged treatment with mitomycin C are known to cause DNA breaks 10 and apoptosis. 11 However, at the mitomycin C concentrations and treatment times used in the division-arrest treatment, there is no evidence for apoptosis or DNA breaks in the division-arrested cells (Z. Zhong, personal communication, 2004). HTS assays run using division-arrested cells are expected to be susceptible to less interference by growth-arresting compounds than assays run using dividing cells. Although this may be advantageous for some screening applications, the use of division-arrested cells will fail to detect antiproliferative compounds that may be of interest for some applications, particularly for the use in anticancer drug screening.
For some cell lines, cryopreservation alone without divisionarrest treatment is sufficient for obtaining the above-stated benefits of consistency and convenience. Weetall et al 12 described the use of cryopreserved, non-division-arrested cell lines for use in a homogeneous adhesion assay. In addition to the Ramos lymphocytic line used in their study, 5 other cryopreserved cell lines were used successfully in the same report. Other authors have used cryopreserved primary cells in quantitative comparisons. 3, 13 Cryopreservation, using techniques that ensure minimum cell death, is a possible alternative for cell division-arrest technology in cellbased assays. However, it is well known that not all cell lines recover well or retain the expression level of particular cell surface receptors after cryopreservation. Obviously, novel or improved cryopreservation methods will be desirable for broader applications in cell-based assays.
In summary, we have evaluated division-arrested cells in 2 different cell-based assays with 2 different cell lines in assays that rely on membrane transport of proteins for readout. The results indicate that the division-arrested cells can be an attractive and viable alter- native to normal dividing cells as cell sources in cell-based HTS. In addition, there are several other areas in which division-arrested cells appear particularly useful, such as for cell-based pharmacological profiling and structure-activity studies and potentially for assays where transient transfection is necessary for signal or where toxicity prevents the generation of a stably transformed line.
